Press Releases Keyword Search Year None20212020201920182017201620152014 Jan 20, 2021 Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Jan 07, 2021 Kala Pharmaceuticals Announces Availability of EYSUVIS™ for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline Jan 04, 2021 Kala Pharmaceuticals to Present at Upcoming Investor Conferences in January
Jan 07, 2021 Kala Pharmaceuticals Announces Availability of EYSUVIS™ for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline